RELEVANT (ETAL-5)
Randomized Evaluation of Treosulfan versus Melphalan Conditioning followed by PTCy in Patients with AML and MDS undergoing Allogeneic Transplantation (RELEVANT)
| Studienleiter | Prof. Dr. med. Stölzel/Dr med. Kunadt |
| EU CT-Nr. | 2023-507879-21-00 |
| Studientyp | Phase II |
| Indikation | AML/MDS |
| ClinicalTrial | NCT07025824 |